pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its financial results for the second quarter of fiscal year 2013 will be released after the market close on Wednesday, February 6, 2013, followed the same day by a conference call and live webcast scheduled for 4:30 p.m. ET.
